ERBB2 and cancer: Not surprisingly, HER2/HER3 dimers are abundant in the HER2 overexpressing MCF7-HER2 cells in the absence of NRG1 and this is consistent with previous report that ligand-independent HER2/HER3 dimerization occurs in high HER2 expressing cancer cells [4].